Login to Your Account



Motif seeks partner for its antibiotic

By Nuala Moran
Staff Writer

Thursday, March 17, 2016

LONDON – Motif Bio plc is now prospecting for commercialization partners to market its hospital-administered antibiotic iclaprim after recruiting the first patient to the pivotal phase III trial at the start of this month.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription